All 34 studies investigating OS were showed that HER2 positive expression in ovarian cancer patients was significantly associated with worse OS (HR = 1.57, 95% CI: 1.31 to 1.89, H2 = 1.7). This evidence concerns the gene ERBB2 and ovarian carcinoma.